Cargando…
The pill of recovery; Molnupiravir for treatment of COVID-19 patients; a systematic review
BACKGROUND: Throughout the time of the global pandemic of SARS-CoV-2 virus, there has been a compelling necessity for the development of effective antiviral agents and prophylactic vaccines to limit the virus spread, disease burden, hospitalization, and mortality. Until mid of 2021, the NIH treatmen...
Autores principales: | Kamal, Lina, Ramadan, Ahmed, Farraj, Suha, Bahig, Lydia, Ezzat, Sameera |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906919/ https://www.ncbi.nlm.nih.gov/pubmed/35287313 http://dx.doi.org/10.1016/j.jsps.2022.03.002 |
Ejemplares similares
-
Molnupiravir for COVID-19
Publicado: (2022) -
Molnupiravir in COVID-19: A systematic review of literature
por: Singh, Awadhesh Kumar, et al.
Publicado: (2021) -
Antiviral Efficacy of Molnupiravir for COVID-19 Treatment
por: Bai, Yuan, et al.
Publicado: (2022) -
What will be the role of molnupiravir in the treatment of COVID-19 infection?
por: Vitiello, Antonio, et al.
Publicado: (2021) -
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
por: Jayk Bernal, Angélica, et al.
Publicado: (2021)